1. Home
  2. PRPL vs ENTX Comparison

PRPL vs ENTX Comparison

Compare PRPL & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.64

Market Cap

76.9M

ML Signal

HOLD

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.16

Market Cap

62.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
ENTX
Founded
2010
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
62.6M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
PRPL
ENTX
Price
$0.64
$1.16
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$0.85
$10.00
AVG Volume (30 Days)
283.1K
175.6K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
152.75
N/A
EPS
0.48
0.25
Revenue
$468,725,000.00
$42,000.00
Revenue This Year
$10.83
N/A
Revenue Next Year
$6.81
N/A
P/E Ratio
$1.25
$4.72
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.91
52 Week High
$1.26
$3.22

Technical Indicators

Market Signals
Indicator
PRPL
ENTX
Relative Strength Index (RSI) 45.72 48.33
Support Level $0.57 $1.17
Resistance Level $0.73 $1.61
Average True Range (ATR) 0.04 0.13
MACD -0.00 0.01
Stochastic Oscillator 24.24 56.25

Price Performance

Historical Comparison
PRPL
ENTX

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: